- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/4709 - Non-condensed quinolines containing further heterocyclic rings
Patent holdings for IPC class A61K 31/4709
Total number of patents in this class: 5630
10-year publication summary
|
401
|
368
|
447
|
437
|
427
|
437
|
380
|
363
|
434
|
124
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 742 |
89 |
| Centre National de La Recherche Scientifique | 10881 |
60 |
| Janssen Pharmaceutica N.V. | 3234 |
55 |
| The Regents of the University of California | 20556 |
54 |
| Bristol-myers Squibb Company | 4812 |
52 |
| Boehringer Ingelheim International GmbH | 4510 |
50 |
| Arog Pharmaceuticals, Inc. | 52 |
47 |
| Gilead Sciences, Inc. | 2186 |
47 |
| Vertex Pharmaceuticals Incorporated | 1601 |
44 |
| F. Hoffmann-La Roche AG | 7839 |
43 |
| Kura Oncology, Inc. | 130 |
38 |
| Institut Curie | 607 |
36 |
| Universite de Montpellier | 1028 |
36 |
| Novartis AG | 10345 |
35 |
| Merck Sharp & Dohme LLC | 3723 |
35 |
| Forma Therapeutics, Inc. | 155 |
34 |
| Abivax | 121 |
33 |
| Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 858 |
33 |
| Merck Patent GmbH | 5663 |
32 |
| Amgen Inc. | 4353 |
32 |
| Other owners | 4745 |